- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 28th, 2004
Cardiff-based Q Chip has agreed the joint venture with FTSE techMark 100-listed Biocompatibles International, a medical device company which is focused on the treatment of cardiovascular disease, cancer and benign tumours.
The Welsh company possesses technology which enables the production of uniform particles at a molecular level. It uses tiny capillaries etched in wafers to precisely create micro and nanoparticles.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016
INVECAS to Enable ASIC Designs for Tomorrow’s Intelligent Systems on GLOBALFOUNDRIES' FDX™ Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX® and 12FDX™ Technologies September 30th, 2016